Calcineurin Inhibitor Based Immunosuppression Withdrawal

NCT02117596 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Renal Transplant

Interventions

DRUG: Sirolimus

Sponsor

Pediatric Nephrology of Alabama

Collaborators

[object Object]
[object Object]